Pancreatic Cancer Research

ResearcherStanford MedicineNo recent work listed

Dhanya K. Nambiar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0648-403X; OpenAlex author ID A5017221987. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. The Combination of Radiotherapy and Complement C3a Inhibition Potentiates Natural Killer cell Functions Against Pancreatic Cancer. First author DOI 10.1158/2767-9764.crc-22-0069↗
  2. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells. Co-author DOI 10.1016/j.canlet.2012.09.004↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Amato J. Giaccia · 1 shared paper, 2022 · strength 0.15
  2. Daniel Tandel Chang · 1 shared paper, 2022 · strength 0.15
  3. Rana Pratap Singh · 1 shared paper, 2013 · strength 0.05
  4. Rajesh Agarwal · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.